Effects of partially hydrogenated fish oil, partially hydrogenated soybean oil, and butter on hemostatic variables in men. 1996

K Almendingen, and I Seljeflot, and B Sandstad, and J I Pedersen
Institute for Nutrition Research, University of Oslo, Norway.

We have compared the effects of partially hydrogenated fish oil (PHFO diet), partially hydrogenated soybean oil (PHSO diet), and butterfat (butter diet) on fibrinolytic and coagulation variables in 31 young men. The three test margarines, which contributed 78% of total fat in the diets, contained 70% butterfat, PHSO, or PHFO, each with 30% of soybean oil. Fat provided approximately 35% of energy, and the content of trans-fatty acids was 0.9%, 8.5%, and 8.0% of energy in the butter diet, PHSO diet, and PHFO diet, respectively. All diets contained 420 mg cholesterol per 10 megajoules per day. All subjects consumed all three test diets for 3 weeks, in a random order (crossover design). The PHSO diet resulted in higher levels of plasminogen activator inhibitor type 1 antigen and plasminogen activator inhibitor type 1 activity than the two other test diets. Fibrinogen increased on the butter diet compared with the PHFO diet. No significant differences in the levels of factor VII, fibrinopeptide A, D-dimer, tissue plasminogen activator or beta-thromboglobulin were observed between the three test diets. The PHFO and the PHSO diets have previously been shown to result in higher levels of Lp(a) compared with the butter diet. The present findings indicate that PHSO has unfavorable antifibrinolytic effects relative to PHFO and butter and that butter may be procoagulant relative to PHFO. More controlled studies are needed to assess definitely the impact of different hydrogenated fats on risk of coronary heart disease.

UI MeSH Term Description Entries
D008297 Male Males
D002079 Butter The fatty portion of milk, separated as a soft yellowish solid when milk or cream is churned. It is processed for cooking and table use. (Random House Unabridged Dictionary, 2d ed) Butters
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D005395 Fish Oils Oils high in unsaturated fats extracted from the bodies of fish or fish parts, especially the LIVER. Those from the liver are usually high in VITAMIN A. The oils are used as DIETARY SUPPLEMENTS. They are also used in soaps and detergents and as protective coatings. Fish Liver Oils,Fish Oil,Liver Oils, Fish,Oil, Fish,Oils, Fish,Oils, Fish Liver
D006487 Hemostasis The process which spontaneously arrests the flow of BLOOD from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements (eg. ERYTHROCYTE AGGREGATION), and the process of BLOOD COAGULATION. Hemostases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006865 Hydrogenation Addition of hydrogen to a compound, especially to an unsaturated fat or fatty acid. (From Stedman, 26th ed) Hydrogenations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013024 Soybean Oil Oil from soybean or soybean plant. Soya Oil,Soy Bean Oil,Oil, Soy Bean,Oil, Soya,Oil, Soybean,Oils, Soy Bean,Oils, Soya,Oils, Soybean,Soy Bean Oils,Soya Oils,Soybean Oils
D017395 Plasminogen Activator Inhibitor 1 A member of the serpin family of proteins. It inhibits both the tissue-type and urokinase-type plasminogen activators. PAI-1,SERPINE1 Protein,Serpin E1,Type 1 Plasminogen Activator Inhibitor,E1, Serpin,Protein, SERPINE1

Related Publications

K Almendingen, and I Seljeflot, and B Sandstad, and J I Pedersen
June 1995, Journal of lipid research,
K Almendingen, and I Seljeflot, and B Sandstad, and J I Pedersen
June 1996, European journal of clinical nutrition,
K Almendingen, and I Seljeflot, and B Sandstad, and J I Pedersen
January 1980, Acta pathologica et microbiologica Scandinavica. Section A, Pathology,
K Almendingen, and I Seljeflot, and B Sandstad, and J I Pedersen
January 2005, Asia Pacific journal of clinical nutrition,
K Almendingen, and I Seljeflot, and B Sandstad, and J I Pedersen
September 1998, Lipids,
K Almendingen, and I Seljeflot, and B Sandstad, and J I Pedersen
March 1983, Lipids,
K Almendingen, and I Seljeflot, and B Sandstad, and J I Pedersen
April 2001, Atherosclerosis,
K Almendingen, and I Seljeflot, and B Sandstad, and J I Pedersen
January 2020, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
K Almendingen, and I Seljeflot, and B Sandstad, and J I Pedersen
September 1973, The Journal of nutrition,
Copied contents to your clipboard!